vigabatrin has been researched along with Demyelinating Diseases in 2 studies
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zonouzi, M | 1 |
| Scafidi, J | 1 |
| Li, P | 1 |
| McEllin, B | 1 |
| Edwards, J | 1 |
| Dupree, JL | 1 |
| Harvey, L | 1 |
| Sun, D | 1 |
| Hübner, CA | 1 |
| Cull-Candy, SG | 1 |
| Farrant, M | 1 |
| Gallo, V | 1 |
| Horton, M | 1 |
| Rafay, M | 1 |
| Del Bigio, MR | 1 |
2 other studies available for vigabatrin and Demyelinating Diseases
| Article | Year |
|---|---|
GABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury.
Topics: Action Potentials; Animals; Animals, Newborn; Asphyxia Neonatorum; Carbachol; Cell Count; Cells, Cul | 2015 |
Pathological evidence of vacuolar myelinopathy in a child following vigabatrin administration.
Topics: Anticonvulsants; Brain; Brain Damage, Chronic; Causality; Cerebral Palsy; Demyelinating Diseases; Di | 2009 |